Safety and Efficacy Study in Patients With Major Depressive Disorder

Clinical trial NCT00896363 · COMPLETED

Trial details

NCT number: NCT00896363
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder

Start date: 2009-04-23
Primary completion: 2010-02-09
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.